Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11937 | 879 | 25.9 | 53% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MUMPS VIRUS | Author keyword | 80 | 66% | 9% | 75 |
2 | MUMPS | Author keyword | 79 | 38% | 19% | 164 |
3 | MUMPS VACCINE | Author keyword | 32 | 70% | 3% | 26 |
4 | MUMPS OUTBREAK | Author keyword | 26 | 100% | 1% | 11 |
5 | SH GENE | Author keyword | 14 | 100% | 1% | 7 |
6 | MUMPS ORCHITIS | Author keyword | 6 | 71% | 1% | 5 |
7 | DVP | Address | 6 | 45% | 1% | 10 |
8 | MUMPS MENINGOENCEPHALITIS | Author keyword | 6 | 100% | 0% | 4 |
9 | MEASLES MUMPS RUBELLA VACCINE | Author keyword | 5 | 25% | 2% | 18 |
10 | MUMPS MENINGITIS | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MUMPS VIRUS | 80 | 66% | 9% | 75 | Search MUMPS+VIRUS | Search MUMPS+VIRUS |
2 | MUMPS | 79 | 38% | 19% | 164 | Search MUMPS | Search MUMPS |
3 | MUMPS VACCINE | 32 | 70% | 3% | 26 | Search MUMPS+VACCINE | Search MUMPS+VACCINE |
4 | MUMPS OUTBREAK | 26 | 100% | 1% | 11 | Search MUMPS+OUTBREAK | Search MUMPS+OUTBREAK |
5 | SH GENE | 14 | 100% | 1% | 7 | Search SH+GENE | Search SH+GENE |
6 | MUMPS ORCHITIS | 6 | 71% | 1% | 5 | Search MUMPS+ORCHITIS | Search MUMPS+ORCHITIS |
7 | MUMPS MENINGOENCEPHALITIS | 6 | 100% | 0% | 4 | Search MUMPS+MENINGOENCEPHALITIS | Search MUMPS+MENINGOENCEPHALITIS |
8 | MEASLES MUMPS RUBELLA VACCINE | 5 | 25% | 2% | 18 | Search MEASLES+MUMPS+RUBELLA+VACCINE | Search MEASLES+MUMPS+RUBELLA+VACCINE |
9 | MUMPS MENINGITIS | 4 | 67% | 0% | 4 | Search MUMPS+MENINGITIS | Search MUMPS+MENINGITIS |
10 | MMR VACCINE | 3 | 19% | 2% | 16 | Search MMR+VACCINE | Search MMR+VACCINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYDROPHOBIC PROTEIN GENE | 37 | 100% | 2% | 14 |
2 | SH GENE | 24 | 46% | 4% | 38 |
3 | POSITION 1081 | 17 | 100% | 1% | 8 |
4 | JERYL LYNN | 11 | 100% | 1% | 6 |
5 | RUBELLA VACCINE | 10 | 19% | 5% | 46 |
6 | MIYAHARA STRAIN | 9 | 83% | 1% | 5 |
7 | NEUROVIRULENCE SAFETY TEST | 8 | 100% | 1% | 5 |
8 | RUBELLA MMR VACCINATIONS | 8 | 100% | 1% | 5 |
9 | HIGHLY VACCINATED POPULATION | 7 | 37% | 2% | 15 |
10 | L ZAGREB | 6 | 100% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Genomic diversity of mumps virus and global distribution of the 12 genotypes | 2015 | 1 | 57 | 96% |
Mumps | 2008 | 104 | 95 | 82% |
Molecular biology, pathogenesis and pathology of mumps virus | 2015 | 1 | 77 | 71% |
Mumps outbreaks in Canada and the United States: Time for new thinking on mumps vaccines | 2007 | 54 | 46 | 83% |
Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks? | 2008 | 54 | 68 | 84% |
The molecular epidemiology of mumps virus | 2004 | 33 | 48 | 98% |
Live attenuated vaccines: Historical successes and current challenges | 2015 | 2 | 78 | 22% |
Vaccine-preventable diseases: the role of the European Centre for Disease Prevention and Control | 2014 | 1 | 1 | 100% |
Mumps vaccine virus strains and aseptic meningitis | 2006 | 22 | 35 | 80% |
The increasing incidence of mumps orchitis: a comprehensive review | 2010 | 9 | 33 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DVP | 6 | 45% | 1.1% | 10 |
2 | DVP OFF VACCINES REVIEW | 3 | 100% | 0.3% | 3 |
3 | MOL BIOMED UNIT | 3 | 32% | 0.8% | 7 |
4 | EUROPEAN PUBL HLTH MICROBIOL TRAINING PROGRAM EPI | 2 | 67% | 0.2% | 2 |
5 | OVRR | 2 | 24% | 0.9% | 8 |
6 | HUMAN VIRAL VACCINES | 2 | 50% | 0.3% | 3 |
7 | MMRHLB | 2 | 43% | 0.3% | 3 |
8 | IMMUNOL SAFETY | 1 | 33% | 0.3% | 3 |
9 | CUMBRIA LANCASHIRE HLTH PROTECT UNIT | 1 | 40% | 0.2% | 2 |
10 | VIRAL VACCINES | 1 | 27% | 0.3% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000200107 | MEASLES//MEASLES VACCINE//MEASLES ELIMINATION |
2 | 0.0000130396 | V PROTEIN//SENDAI VIRUS//PARAMYXOVIRUS |
3 | 0.0000106715 | CONGENITAL RUBELLA SYNDROME//RUBELLA VIRUS//RUBELLA |
4 | 0.0000081908 | C18L GENE//GO GENE ONTOLOGY//KEGG KYOTO ENCYCLOPEDIA OF GENES AND GENOMES |
5 | 0.0000080068 | FLUOROSCEIN ISOTHIOCYANATE//INFLUENZA A H1N12009//LUCIFER YELLOW CARBOHYDRAZIDE |
6 | 0.0000063643 | MEASLES VIRUS//SSPE VIRUS//VIROL IMMUNOBIOL |
7 | 0.0000048998 | IMMUNIZAT PROGRAM//IMMUNIZATION//VACCINE HESITANCY |
8 | 0.0000040385 | VARICELLA//CHICKENPOX//VARICELLA VACCINE |
9 | 0.0000037203 | GELATIN ALLERGY//VACCINE ALLERGY//ITCHING NODULE |
10 | 0.0000034748 | CHANDIPURA VIRUS//VESICULAR STOMATITIS VIRUS//VESICULAR STOMATITIS |